Evidence map›Paper›PMID 41128887›Full record

ArticleCancer immunology, immunotherapy : CII2025

Identification of two distinct uveal melanoma subtypes based on the immune cell infiltration of the primary tumour.

Konstantinos Panagiotidis, Sally Owens, Grainne Finegan, Noel Horgan, Stefanos Tsavdaridis, Susan Kennedy, Achilleas Floudas

Abstract read
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Konstantinos PanagiotidisSchool of Biotechnology, Dublin City University, Dublin, Ireland.
Sally OwensResearch Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
Grainne FineganSchool of Biotechnology, Dublin City University, Dublin, Ireland.
Noel HorganResearch Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
Stefanos TsavdaridisLaboratory of Biology, Medical School, University of Ioannina, Ioannina, Greece.
Susan KennedyResearch Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
Achilleas FloudasSchool of Biotechnology, Dublin City University, Dublin, Ireland. achilleas.floudas@uoi.gr.

Funding

Health Research Board HRB-EIA2002-002Hellenic Foundation for Research and Innovation 24889
6 · The paper itself

Abstract

backgroundUveal melanoma (UM) is the most common intraocular malignancy, with poor prognosis in metastatic cases and limited response to conventional therapies. Despite advances in genetic stratification, the immunological landscape of primary UM remains poorly understood.

methodsSecondary data generation of single-cell RNA sequencing (scRNA-seq) of primary class 1 and class 2 (loss of BAP1) UM tumours and flow cytometric analysis of 8 primary UM tumour biopsies were used to characterize the tumour microenvironment, cellular composition, tumour-immune cell interactions, and stromal marker expression associated with tumour progression and immune infiltration.

resultsscRNA-seq analysis revealed 16 distinct cell clusters, including melanocytes, T cells, macrophages, and stromal cells. Class 2 tumours contained unique melanocyte subpopulations exhibiting chromosome 8 copy number variations and enriched in hypoxia, PI3K-Akt, and MAPK signalling pathways. Ligand-receptor analysis identified extensive interactions between these aggressive melanocytes and pericytes/macrophages. Flow cytometric analysis confirmed two distinct immune infiltrate profiles: low-infiltrate tumours dominated by CD14⁺ cells, and high-infiltrate tumours with CD8⁺ memory-like T cells expressing PD-1 and CD27. Stromal marker analysis revealed elevated expression of CD81 and NGFR in immune-excluded tumours, implicating them in metastatic potential.

conclusionsOur study reveals cellular and immunological heterogeneity within primary UM tumours. The identification of immunologically distinct tumour types, along with aggressive melanocyte subpopulations and stromal interactions, provides insight into UM pathogenesis and supports stratified immunotherapeutic approaches.

Indexed as

Lymphocytes, Tumor-InfiltratingMelanomaUveal NeoplasmsBiomarkers, TumorFemaleHumansMaleMelanocytesMiddle AgedSingle-Cell AnalysisTumor MicroenvironmentTumor Suppressor ProteinsUbiquitin ThiolesteraseUveal MelanomaBAP1 protein, humanBiomarkers, TumorTumor Suppressor ProteinsUbiquitin ThiolesteraseLymphoidMyeloidRNAseqT cellsUveal melanoma

Identifiers

PMID41128887
PMCPMC12549448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.